Published: 14 April 2023
1h 10m 43sPart 2 | Session 1 Welcome and Lesion significance assessment
1h 2m 7sPart 2 | Session 3 Procedural planning
52m 28sPart 2 | Session 4 Imaging for special indications
57m 15sPart 2 | Session 5 Live case 2 Catharina Hospital, Eindhoven, NL
1h 13m 28sPart 2 | Session 6 PCI optimisation
1h 5m 38sPart 1 | Session 1 Welcome and Current options for plaque characterisation Joost Daemen, Gijs van Soest, Hector M Garcia-Garcia, Richard A Shlofmitz, Giulio Guagliumi, David Erlinge, Alexander Hirsch
44m 3sPart 1 | Session 2 Keynote lecture: Learn IVUS from the Master Ton van der Steen, Gary Mintz
1h 10m 30sPart 1 | Session 3 Future options for plaque characterisation: device empowered Ton van der Steen, Brett Bouma, Gijs van Soest, Laura Marcu, Ziad A Ali
1h 5m 32sPart 1 | Session 4 Future options for plaque characterisation: computationally empowered Gijs van Soest, Hector M Garcia-Garcia, Shengnan Liu, Shengxian Tu, Frank Gijsen, Jolanda Wentzel
49m 22sPart 1 | Session 5 Live case 1 Erasmus University Medical Center, Rotterdam, NL Giulio Guagliumi, Elvin Kedhi, Natalia Pinilla-Echeverri, James Spratt, Evan Shlofmitz
iPCI 2023 was a live two-day event, held on the 13–14 April at the LantarenVenster theatre in Rotterdam, NL. Focusing on image guidance techniques in interventional cardiology, with an educational focus on state-of-the-art imaging and physiology research, iPCI was led by a global faculty of over 35 physicians and engineers.
Led by Course Directors Dr Joost Daemen and Prof Dr Gijs van Soest (Thoraxcenter, Erasmus University Medical Center, Rotterdam, NL) iPCI aimed to optimise theoretical and practical education to maximise patient outcomes.
iPCI is a successor of Optics in Cardiology, which ran five exciting editions from 2011. For the first time, the dissemination of iPCI sessions extended beyond the venue – a free-to-access live virtual broadcast was open to physicians globally.
- Understand invasive plaque characterisation using existing technologies
- Learn about state-of-the-art plaque characterisation using novel technologies and combined imaging modalities
- Get hands-on experience with current IVUS and OCT modalities to recognise different types of plaque
- Learn about the impact of pharmacotherapeutic agents on plaque progression
- Learn how to assess the physiological impact of coronary plaques using the most recent technological developments
- Learn how to do procedural planning using state-of-the-art coronary imaging and physiology tools
- Understand the principles of PCI optimisation using intracoronary imaging and physiology
- Interventional Cardiologists
- Biomedical Imaging Engineers
More from this programme
Director of Interventional Cardiology Research and Associate Director, Cardiac Catheterization
Dr Allen Jeremias, MD, MSc is an interventional cardiologist at St. Francis Hospital, Roslyn, NY and Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory. He is also the Director of the Physiology Core Laboratory at the Cardiovascular Research Foundation, New York, NY.
Dr Jeremias earned his medical degree at Heinrich-Heine-University School of Medicine in Düsseldorf, Germany, and a Master of Science degree at Harvard Medical School. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, as well as Beth Israel Deaconess Medical Center, Harvard Medical School.
Prof Takashi Akasaka is an Interventional Cardiologist at Wakayama Medical University, Wakayama, JP.
He graduated from Wakayama Medical University in 1982 and finished his residency at Kobe City Medical Center General Hospital.
Since 2005 he has been devoted to the clinical research work using OCT.
Hector M Garcia-Garcia
Dr Hector Garcia-Garcia is director of angiographic, intravascular ultrasound, optical coherence tomography and near infrared spectroscopy imaging at the Cardiovascular Core Laboratory, MedStar Cardiovascular Research Network, MedStar Washington Hospital Center (MWHC). He is also chairman of the Clinical Event committee and an attending cardiologist at MedStar Heart and Vascular Institute, MWHC.
Prior to joining MedStar, he served as director of the core invasive imaging laboratory at a clinical research organisation and as a researcher at the Erasmus Medical Center, Rotterdam. He obtained his degree from the Universidad Autónoma de Guadalajara, Mexico. He completed a residency in cardiology and a fellowship in interventional cardiology at the Instituto Nacional de Cardiologia Ignacio Chavez and the Universidad Nacional Autónoma de Mexico. His master’s degree in epidemiology and his doctorate degree in clinical research are from the Erasmus University Rotterdam, the…
Head of the Cardiology Department
Prof David Erlinge is Head of the Cardiology Department at Skane University Hospital, Lund, SE. He graduated in medicine from the University of Lund, in 1990, where he also earned his Ph.D.
In 2006 he received the Lars Werkö distinguished research fellowship and was appointed Professor in Cardiology at Lund University in 2008.
Prof Erlinge’s clinical specialty is invasive cardiology (PCI) and his main research interests include acute coronary syndromes, platelet function, and cardioprotection.
Dr Joost Daemen, MD, PhD obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Joost is actively involved in several drug-eluting stent trials and is Principal Investigator of 4 trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Joost is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Prof Isabella Kardys is a Cardiovascular Epidemiologist at Erasmus University Medical Center, Rotterdam, NL.